Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Why Alembic Pharma Is A Great Stock To Buy Even Now



Alembic Pharma has a great run on the stock exchange with a 181% YOY return. However, given its’ high ROE, size of opportunity and reasonable valuations, there is still a lot of scope for gain in the stock says Meeta Shetty, CFA, of HDFC Securities




meeta_shetty_HDFC

Alembic Pharma is “Gearing for a leap” says Meeta Shetty of HDFC Securities in her initiating coverage report. Meeta Shetty has given convincing reasons that in view of the high CAGR of revenue, high ROE/ROCE of 40% +, the consistent free cash flows and high margin product opportunities, there is still great opportunity for gain in Alembic Pharma.

Click here to download HDFC Sec’s Alembic Pharma Research Report
investments, Mid Cap, Multibagger, Portfolio, stock picker   

3 Comments
  1. jalil inamdar's Gravatar jalil inamdar
    March 23, 2014 at 12:14 pm | Permalink

    I want buy alembice fharma. Its right price. I want hold 10 years

    Reply
  2. Kalyan's Gravatar Kalyan
    March 23, 2014 at 4:50 pm | Permalink

    It has really run up and after this report, it will go up even further, in the immediate short run. Is it worth the risk?

    Reply
    • Kalyan's Gravatar Kalyan
      March 29, 2014 at 6:06 pm | Permalink

      I have added a decent quantity, inspite of my caution above. So far, it had looked good and I made use (to enter) of 1 day when it crashed 6%

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 496 other subscribers

RSS Stocks Talk Forum

  • Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide
    Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide. Singhania's Abakkus Fund holds 6.78% worth ₹137 Cr. Kela's Cohesion MK Fund holds 4.07% worth ₹82 Cr. M-Cap is ₹2100 Cr. Promoters hold 37%. Co is dominant in branded Home Textile with a 'fibre to shelf' model
  • Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
    Suraj Estate Developers has a robust project lineup & launch pipeline, leadership position in redevelopment projects, strong cost advantage, proven track record, huge addressable market and healthy Balance Sheet with predictable cash flows. TP ₹992 (+73%) Download research report... Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
  • DCX Systems has the ability to become a key player in EMS space. TP ₹466 (+54%)
    DCX Systems has the ability to become a key player in EMS space with huge potential in railway & defence. It has ability to deliver high value complicated & critical products for leading defense players L&T & Lockheed. Order book ₹3000 Cr. TP ₹466 (+54%) Download... DCX Systems has the ability to become a key […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!